Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

If Magnificent 7 Executives Don’t Believe In Their Stocks, Should You?

Opening Bell: April 7, 2026

NYSE Content Update: Starfish Space Adds Over $100 Million in Funding to Boost Growth

UBS lowers 2026 S&P 500 target on Middle East conflict risks

PowerBank Wins NYSERDA Incentive for New York Community Solar as Nasdaq Listing Risk Emerges